Skip to main content
. 2020 Nov 3;10:18879. doi: 10.1038/s41598-020-75306-z

Figure 3.

Figure 3

Differences in fecal metabolites between patients and controls, responders and non-responders and the effect of EEN on the fecal metabolome. Panels (AC) show OPLS-DA plots. This analysis indicates that 1HNMR analysis can distinguish controls (blue) from patients (red) at T0, panel (A). A marginal EEN induced change in metabolome from T0 (red) to T2 (blue) is shown in panel (B). The difference in metabolome between responders (blue) and non-responders (red) at T0 is shown in panel (C). Panel (D) shows increased total fecal amino acids in patients that decrease during EEN therapy. Panel (E) shows that bile salts are not elevated in patients and unchanged during therapy. Panels (F) and (G) show decreased bile salt metabolism and hydrophobicity in patients at T0 that is partially normalized during therapy. Panels (H) and (I) show increased levels of trimethylamine and cadaverine respectively and show partial normalization of these compounds during EEN therapy. HC healthy controls, R responders, NR non-responders.